Drawing for RAXCEEVA

USPTO serial 79248499

RAXCEEVA

Reviewed by CopyMark Law Group

Reg. 5742339Status 404
Filing date
Status date
Registration date
May 7, 2019
Examiner
MURRAY, DAVID T
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RAXCEEVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Sep 3, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 18, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jun 29, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 29, 2019FIMPFINAL DISPOSITION PROCESSED—
Jun 6, 2019GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
May 7, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 22, 2019GPNXNOTIFICATION PROCESSED BY IB—
Feb 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 6, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 6, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 30, 2019NPUBNOTICE OF PUBLICATION—
Jan 15, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 9, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 9, 2019DOCKASSIGNED TO EXAMINER—
Jan 9, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 31, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 27, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance